Company intelligence / Profile preview

BrightView Health

Various, Kentucky, United Statesbrightview.com ↗

Ownership: Private
Development stage: Other

Overview

BrightView Health operates over 80 outpatient addiction medicine centers across eight states, providing evidence-based care for substance use disorders and opioid use disorders. The company has partnered with Pear Therapeutics to offer FDA-authorized prescription digital therapeutics reSET and reSET-O, expanding access to innovative digital treatments for SUD and OUD. Clinical results from these digital therapeutics have been published in peer-reviewed journals[5].

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapyDigital therapeutic (via partnership with Pear Therapeutics)Medication-assisted treatment (MAT) (likely includes small molecule medications such as buprenorphine and naltrexone)
Industry: Non-Academic Healthcare

Partnerships

Pear Therapeutics[5]

Beyond the preview

Go deeper on BrightView Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrightView Health.

Explore the full profile